{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:34:26Z","timestamp":1788233666270,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> SLC13A5 citrate transporter disorder is a rare autosomal recessive genetic disease that has a constellation of neurologic symptoms. To better characterize the neurologic and clinical laboratory phenotype, we utilized patient medical records collected by Ciitizen, an Invitae company, with support from the TESS Research Foundation.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Medical records for 15 patients with a suspected genetic and clinical diagnosis of SLC13A5 citrate transporter disorder were collected by Ciitizen, an Invitae company. Genotype, clinical phenotypes, and laboratory data were extracted and analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The 15 patients reported all had epilepsy and global developmental delay. Patients continued to attain motor milestones, though much later than their typically developing peers. Clinical diagnoses support abnormalities in communication, and low or mixed tone with several movement disorders, including, ataxia and dystonia. Serum citrate was elevated in the 3 patients in whom it was measured; other routine laboratory studies assessing renal, liver and blood function had normal values or no consistent abnormalities. Many electroencephalograms (EEGs) were performed (1 to 35 per patient), and most but not all were abnormal, with slowing and\/or epileptiform activity. Fourteen of the patients had one or more brain magnetic resonance imaging (MRI) reports: 7 patients had at least one normal brain MRI, but not with any consistent findings except white matter signal changes.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> These results show that in addition to the epilepsy phenotype, SLC13A5 citrate transporter disorder impacts global development, with marked abnormalities in motor abilities, tone, coordination, and communication skills. Further, utilizing cloud-based medical records allows industry, academic, and patient advocacy group collaboration to provide preliminary characterization of a rare genetic disorder. Additional characterization of the neurologic phenotype will be critical to future study and developing treatment for this and related rare genetic disorders.<\/jats:p>","DOI":"10.3389\/fgene.2023.1109547","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T05:17:02Z","timestamp":1679375822000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system"],"prefix":"10.3389","volume":"14","author":[{"given":"Emily M.","family":"Spelbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Brimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten A.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Nye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda E.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/8904_2016_546","article-title":"Disease heterogeneity in Na+\/Citrate cotransporter deficiency","volume":"31","author":"Anselm","year":"2016","journal-title":"JIMD Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1002\/ajmg.a.61802","article-title":"Adult phenotype of the homozygous missense mutation c.655G>A, p.Gly219Arg in SLC13A5: A case report","volume":"182","author":"Arvio","year":"2020","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ymgme.2017.06.009","article-title":"Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle","volume":"121","author":"Bainbridge","year":"2017","journal-title":"Mol. Genet. metabolism"},{"key":"B42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/metabo11110746","article-title":"Growth and overall health of patients with SLC13A5 citrate transporter disorder","volume":"11","author":"Brown","year":"2021","journal-title":"Metabolites"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s00415-021-10808-y","article-title":"The phenotypic spectrum of KCNT1: A new family with variable epilepsy syndromes including mild focal epilepsy","volume":"269","author":"Cherian","year":"2022","journal-title":"J. Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13023-021-01806-4","article-title":"Data silos are undermining drug development and failing rare disease patients","volume":"16","author":"Denton","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13023-022-02529-w","article-title":"Sharing is caring: A call for a new era of rare disease research and development","volume":"17","author":"Denton","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2212178119","DOI":"10.1073\/pnas.2212178119","article-title":"A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth","volume":"119","author":"Dirckx","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62192","article-title":"A novel homozygous SLC13A5 whole-gene deletion generated by Alu\/Alu-mediated rearrangement in an Iraqi family with epileptic encephalopathy","author":"Duan","year":"2021","journal-title":"Am. J. Med. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","article-title":"Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: A systematic review of observational studies","volume":"377","author":"Fleming","year":"2011","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-3476(67)80070-2","article-title":"The denver developmental screening test","volume":"71","author":"Frankenburg","year":"1967","journal-title":"J. Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.113.01275","article-title":"White-coat hypertension: New insights from recent studies","volume":"62","author":"Franklin","year":"2013","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/genes13091655","article-title":"SLC13A5 deficiency disorder: From genetics to gene therapy","volume":"13","author":"Goodspeed","year":"2022","journal-title":"Genes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"G402","DOI":"10.1152\/ajpgi.00371.2006","article-title":"Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines","volume":"292","author":"Gopal","year":"2007","journal-title":"Am. J. Physiology-Gastrointestinal Liver Physiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymgme.2008.10.003","article-title":"Clinical research for rare disease: Opportunities, challenges, and solutions","volume":"96","author":"Griggs","year":"2009","journal-title":"Mol. Genet. Metabolism"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","article-title":"How many rare diseases are there?","volume":"19","author":"Haendel","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1093\/brain\/awv263","article-title":"Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia","volume":"138","author":"Hardies","year":"2015","journal-title":"Brain A J. Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105018","DOI":"10.1016\/j.nbd.2020.105018","article-title":"Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus","volume":"143","author":"Henke","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0006-291X(02)02669-4","article-title":"Human Na+-coupled citrate transporter: Primary structure, genomic organization, and transport function","volume":"299","author":"Inoue","year":"2002","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/gt.2017.29","article-title":"The importance of international collaboration for rare diseases research: A European perspective","volume":"24","author":"Julkowska","year":"2017","journal-title":"Gene Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2119\/molmed.2016.00077","article-title":"Mutations in the Na+\/Citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay","volume":"22","author":"Klotz","year":"2016","journal-title":"Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"109701","DOI":"10.1101\/2021.04.08.439058","article-title":"NaCT (SLC13A5) facilitates citrate import and metabolism under nutrient-limited conditions","volume":"36","author":"Kumar","year":"2021","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1111\/epi.16699","article-title":"Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene","volume":"61","author":"Matricardi","year":"2020","journal-title":"Epilepsia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13023-016-0445-8","article-title":"The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network","volume":"11","author":"Merkel","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"B25","article-title":"Pub L. No. 97-414, 96 Stat.2049","year":"1983"},{"key":"B26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1124\/mol.116.105049","article-title":"Molecular basis for inhibition of the Na +\/citrate transporter NaCT (SLC13A5) by dicarboxylate inhibitors","volume":"90","author":"Pajor","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"C1215","DOI":"10.1152\/ajpcell.2001.280.5.C1215","article-title":"Cloning and functional characterization of a high-affinity Na+\/dicarboxylate cotransporter from mouse brain","volume":"280","author":"Pajor","year":"2001","journal-title":"Am. J. Physiology-Cell Physiology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpn.2019.12.016","article-title":"The phenotypic spectrum of SCN2A-related epilepsy","volume":"24","author":"Reynolds","year":"2020","journal-title":"Eur. J. Paediatr. Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-021-03230-x","article-title":"Structure and inhibition mechanism of the human citrate transporter NaCT","volume":"591","author":"Sauer","year":"2021","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejpn.2019.12.023","article-title":"Deciphering the concepts behind \u201cEpileptic encephalopathy\u201d and \u201cDevelopmental and epileptic encephalopathy\u201d","volume":"24","author":"Scheffer","year":"2020","journal-title":"Eur. J. Paediatr. Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/jmedgenet-2016-103988","article-title":"SLC13A5 is the second gene associated with Kohlsch\u00fctter\u2013T\u00f6nz syndrome","volume":"54","author":"Schossig","year":"2017","journal-title":"J. Med. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1038\/s41598-018-29547-8","article-title":"Analysis of naturally occurring mutations in the human uptake transporter NaCT important for bone and brain development and energy metabolism","volume":"8","author":"Selch","year":"2018","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5698\/1535-7511-16.4.273","article-title":"Epileptic encephalopathy in infants and children","volume":"16","author":"Stafstrom","year":"2016","journal-title":"Epilepsy Curr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ajhg.2014.06.006","article-title":"Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life","volume":"95","author":"Thevenon","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13023-021-02061-3","article-title":"The IDeaS initiative: Pilot study to assess the impact of rare diseases on patients and healthcare systems","volume":"16","author":"Tisdale","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejpn.2016.11.002","article-title":"Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations","volume":"21","author":"Weeke","year":"2017","journal-title":"Eur. J. Paediatr. Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.seizure.2023.01.014","article-title":"The neuroimaging spectrum of SLC13A5 related developmental and epileptic encephalopathy","volume":"106","author":"Whitney","year":"2023","journal-title":"Seizure"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e136083","DOI":"10.1172\/jci.insight.136083","article-title":"The longevity gene mIndy (I\u2019m Not Dead, Yet) affects blood pressure through sympathoadrenal mechanisms","volume":"6","author":"Willmes","year":"2021","journal-title":"JCI Insight"},{"key":"B40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","article-title":"The national economic burden of rare disease in the United States in 2019","volume":"17","author":"Yang","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2329048X20931361","DOI":"10.1177\/2329048X20931361","article-title":"Epilepsy and EEG phenotype of SLC13A5 citrate transporter disorder","volume":"7","author":"Yang","year":"2020","journal-title":"Child. Neurol. Open"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1109547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T05:17:04Z","timestamp":1679375824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1109547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":42,"alternative-id":["10.3389\/fgene.2023.1109547"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1109547","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"article-number":"1109547"}}